HYDERABAD, India--(BUSINESS WIRE)--Cellix Bio Pharma completes the acquisition of Avaca Pharma, a formulation development company. Avaca Pharma services include discovery, formulation development, ...

NEWARK, N.J.--(BUSINESS WIRE)--Cellix Biosciences Inc. (“Cellix Bio”), a development-stage pharmaceutical company, today announced confirmation from the U.S. Food and Drug Administration (FDA) that ...

The acquisition strengthens an already existing collaboration between the companies to advance clinical development of therapies across multiple drug categories. On Feb. 06, 2018, V ClinBio, a ...

Cellix’ Drug Discovery System Strives to Reproduce In Vivo Microenvironments Researchers working in drug discovery “have to think outside the box to insure a higher success rate for their clinical ...

Trinity College Dublin (TCD) graduate Vivienne Williams and co-founder of medical device manufacturer Cellix has won the Trinity Innovation Award. Williams’ company originated from within TCD ...

Founded in 2014, Cellix Bio operates in Enterprise Tech industry. Initially focused on innovative solutions, the company has emerged as a significant player in the ...

- Lead compounds for the treatment of relapsing-remitting multiple sclerosis and ulcerative colitis on target to enter clinic in 2018 - PRINCETON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- V ClinBio Inc ...

Cellix Ltd. has announced that its worldwide launch of its VenaFlux™ Platform. The VenaFlux™, the first semi-automated, high throughput microfluidic cell- based assay system, measures cell adhesion to ...

Cellix Biosciences Inc. ("Cellix Bio"), a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and ...

"Presbyopia Pipeline Analysis & Clinical Trials Assessment"DelveInsight's,“Presbyopia - Pipeline Insight, 2025” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in ...